Abstract

Molecular profiling has emerged as a transformative tool in cancer research, offering insights into the genetic and molecular landscape of tumors. By analyzing tumor-specific alterations, researchers can identify potential therapeutic targets, enabling more personalized treatment strategies. This article reviews the methodologies employed in molecular profiling, including next-generation sequencing (NGS), gene expression analysis, and proteomics. We discuss the implications of these techniques for discovering novel biomarkers, understanding tumor heterogeneity, and informing targeted therapies. Additionally, we address the challenges associated with integrating molecular profiling into clinical practice and highlight future directions for research and development in this evolving field. Ultimately, molecular profiling holds the promise of significantly improving cancer treatment outcomes by enabling precision medicine approaches.